Lifestyle Modification and Prevention of Type 2 Diabetes in Overweight Japanese With Impaired Fasting Glucose Levels A Randomized Controlled Trial

被引:224
作者
Saito, Toshikazu [1 ]
Watanabe, Makoto [6 ]
Nishida, Junko
Izumi, Tomono
Omura, Masao
Takagi, Toshikazu [3 ]
Fukunaga, Ryuzo [7 ]
Bandai, Yasutsugu [2 ]
Tajima, Naoko [4 ]
Nakamura, Yosikazu [8 ]
Ito, Masaharu [5 ]
机构
[1] Social Insurance Chuo Gen Hosp, Dept Internal Med, Shinjyuku Ku, Tokyo 1690073, Japan
[2] Social Insurance Chuo Gen Hosp, Dept Surg, Tokyo 1690073, Japan
[3] Ikebukuro Hosp, Dept Internal Med, Tokyo, Japan
[4] Jikei Univ, Sch Med, Dept Internal Med, Tokyo, Japan
[5] All Japan Federat Social Insurance Assoc, Tokyo, Japan
[6] Natl Cerebral & Cardiovasc Ctr, Dept Prevent Cardiol, Osaka, Japan
[7] Hoshigaoka Employees Pens Welf Hosp, Dept Strokol, Osaka, Japan
[8] Jichi Med Univ, Dept Publ Hlth, Shimotsuke, Tochigi, Japan
关键词
PREVALENCE; INTERVENTION; TOLERANCE; IGT;
D O I
10.1001/archinternmed.2011.275
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Previous studies demonstrated that intensive lifestyle modification can prevent type 2 diabetes mellitus among those with impaired glucose tolerance, but similar beneficial results have not been proved among those with impaired fasting glucose levels. We investigated the efficacy of lifestyle modification on type 2 diabetes incidence among those with impaired fasting glucose levels. Methods: The present study was an unmasked, multicenter, randomized, controlled trial. A total of 641 overweight Japanese (aged 30-60 years) with impaired fasting glucose levels were recruited nationwide in Japan and randomly assigned to a frequent intervention group (n=311) or a control group (n=330). For 36 months after randomization, the frequent intervention group received individual instructions and follow-up support for lifestyle modification from the medical staff 9 times. The control group received similar individual instructions 4 times at 12-month intervals during the same period. The primary outcome was type 2 diabetes incidence in annual 75-g oral glucose tolerance tests, diagnosed according to World Health Organization criteria. Results: There were no significant differences between the allocation groups in baseline characteristics and dropout rates. Estimated cumulative incidences of type 2 diabetes were 12.2% in the frequent intervention group and 16.6% in the control group. Overall, the adjusted hazard ratio in the frequent intervention group was 0.56 (95% confidence interval, 0.36-0.87). In the post hoc subgroup analyses, the hazard ratio reduced to 0.41 (95% confidence interval, 0.24-0.69) among participants with impaired glucose tolerance at baseline, and to 0.24 (0.12-0.48) among those with baseline hemoglobin A(1c) levels of 5.6% or more (the Japan Diabetes Society method). Such risk reduction was not observed among those with isolated impaired fasting glucose findings or baseline hemoglobin A(1c) levels of less than 5.6%. Conclusions: Lifestyle modifications can prevent type 2 diabetes among overweight Japanese with impaired fasting glucose levels. In addition, identifying individuals with more deteriorated glycemic status by using 75-g oral glucose tolerance test findings or, especially, measurement of hemoglobin A(1c) levels, could enhance the efficacy of lifestyle modifications.
引用
收藏
页码:1352 / 1360
页数:9
相关论文
共 18 条
  • [1] Calculating the number needed to treat for trials where the outcome is time to an event
    Altman, DG
    Andersen, PK
    [J]. BRITISH MEDICAL JOURNAL, 1999, 319 (7223) : 1492 - 1495
  • [2] [Anonymous], 1999, Definition, diagnosis, and classification of diabetes mellitus and its complications: report of a WHO consultation
  • [3] [Anonymous], RINSHO KAGAKU
  • [4] [Anonymous], EKUSERU EIYOUKUN VER
  • [5] Is haemoglobin A1c a step forward for diagnosing diabetes?
    Kilpatrick, Eric S.
    Bloomgarden, Zachary T.
    Zimmet, Paul Z.
    [J]. BRITISH MEDICAL JOURNAL, 2009, 339
  • [6] Global burden of diabetes, 1995-2025 - Prevalence, numerical estimates, and projections
    King, H
    Aubert, RE
    Herman, WH
    [J]. DIABETES CARE, 1998, 21 (09) : 1414 - 1431
  • [7] Knowler William C, 2002, N Engl J Med, V346, P393, DOI 10.1056/NEJMoa012512
  • [8] Prevention of type 2 diabetes by lifestyle intervention: a Japanese trial in IGT males
    Kosaka, K
    Noda, M
    Kuzuya, T
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2005, 67 (02) : 152 - 162
  • [9] International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of Diabetes
    Nathan, David M.
    Nathan, David M.
    Balkau, Beverly
    Bonora, Enzo
    Borch-Johnsen, Knut
    Buse, John B.
    Colagiuri, Stephen
    Davidson, Mayer B.
    DeFronzo, Ralph
    Genuth, Saul
    Holman, Rury R.
    Ji, Linong
    Kirkman, Sue
    Knowler, William C.
    Schatz, Desmond
    Shaw, Jonathan
    Sobngwi, Eugene
    Steffes, Michael
    Vaccaro, Olga
    Wareham, Nick
    Zinman, Bernard
    Kahn, Richard
    [J]. DIABETES CARE, 2009, 32 (07) : 1327 - 1334
  • [10] Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance - The Da Qing IGT and diabetes study
    Pan, XR
    Li, GW
    Hu, YH
    Wang, JX
    Yang, WY
    An, ZX
    Hu, ZX
    Lin, J
    Xiao, JZ
    Cao, HB
    Liu, PA
    Jiang, XG
    Jiang, YY
    Wang, JP
    Zheng, H
    Zhang, H
    Bennett, PH
    Howard, BV
    [J]. DIABETES CARE, 1997, 20 (04) : 537 - 544